The document discusses several substance-related disorders including substance abuse, alcohol-related disorders, amphetamine-related disorders, caffeine-related disorders, cannabis-related disorders, cocaine-related disorders, and hallucinogen-related disorders. It provides information on the diagnostic criteria, physiological and psychological effects, mechanisms of action, pharmacokinetics, and treatment approaches for managing withdrawal and dependence for each substance.
Substance abuse refers to disorders arising from the abuse of alcohol, drugs, and other chemicals. It is classified as F1 in ICD-10. Addiction involves physiological and psychological dependence on a substance, while abuse refers to impaired health. Dependence involves tolerance and withdrawal symptoms. Alcohol dependence is a chronic condition characterized by excessive and compulsive drinking that impairs functioning. It commonly leads to physical and psychological dependence as well as health, social, and legal problems. Relapse is the return to substance abuse after a period of abstinence.
This document discusses addictive behaviors and substance abuse disorders. It defines addiction as a pathological need for a substance or activity, which can involve abuse of drugs like nicotine, alcohol, or cocaine. Addictive disorders are prevalent in society and cause major health problems. Commonly abused substances that affect mental functioning include alcohol, nicotine, tranquilizers, and marijuana. Both substance abuse and dependence are explained, with dependence involving physiological symptoms like tolerance and withdrawal. The biological, psychological, and social factors contributing to addiction are explored. Treatment aims to address detoxification, behavior control, and helping individuals cope without the substance.
Substance abuse, also known as drug abuse, is a patterned use of a drug in which the user consumes the substance in amounts or with methods which are harmful to themselves or others, and is a form of the substance-related disorder.
We know that if a person is consuming something like drug or alcohol he or she is taking something extra to his or her body which is harmful for the health of individual or for others also.
Drug addiction is a chronic disease characterized by drug seeking and use that is compulsive, or difficult to control, despite harmful consequences.
Brain changes that occur over time with drug use challenge an addicted person’s self-control and interfere with their ability to resist intense urges to take drugs. This is why drug addiction is also a relapsing disease.
Relapse is the return to drug use after an attempt to stop. Relapse indicates the need for more or different treatment.
Most drugs affect the brain's reward circuit by flooding it with the chemical messenger dopamine. This overstimulation of the reward circuit causes the intensely pleasurable "high" that leads people to take a drug again and again.
Drugs alter normal bodily functions by changing emotions and thoughts when absorbed into the body. Drug abuse is an intense desire to obtain drugs that results in physical harm and behavior problems over the long term. Substance abusers use substances in a way that damages themselves or society, while substance abuse counselors have training to help with addiction issues across different aspects. Substance abuse is a major problem impacting many in society as the most prevalent mental disorder and continuing health issue, with approximately 6-25% of the US population struggling with addiction or abuse of various legal and illegal substances.
This document discusses alcohol use disorders and their management. It begins with an overview of the epidemiology, terminology, classification, and complications of alcohol use disorders. Globally, around 107 million people have an alcohol use disorder, with prevalence in India being 1.12%. The reward pathway in the brain is stimulated by substances like alcohol. Screening tools can identify alcohol use and abuse. Management includes detoxification using benzodiazepines, treating comorbidities, using anti-craving drugs like Naltrexone or Acamprosate, and psychological therapies like motivational enhancement and group therapy. Follow up is also important for management.
Substance abuse refers to disorders arising from the abuse of alcohol, drugs, and other chemicals. It is classified as F1 in ICD-10. Addiction involves physiological and psychological dependence on a substance, while abuse refers to impaired health. Dependence involves tolerance and withdrawal symptoms. Alcohol dependence is a chronic condition characterized by excessive and compulsive drinking that impairs functioning. It commonly leads to physical and psychological dependence as well as health, social, and legal problems. Relapse is the return to substance abuse after a period of abstinence.
This document discusses addictive behaviors and substance abuse disorders. It defines addiction as a pathological need for a substance or activity, which can involve abuse of drugs like nicotine, alcohol, or cocaine. Addictive disorders are prevalent in society and cause major health problems. Commonly abused substances that affect mental functioning include alcohol, nicotine, tranquilizers, and marijuana. Both substance abuse and dependence are explained, with dependence involving physiological symptoms like tolerance and withdrawal. The biological, psychological, and social factors contributing to addiction are explored. Treatment aims to address detoxification, behavior control, and helping individuals cope without the substance.
Substance abuse, also known as drug abuse, is a patterned use of a drug in which the user consumes the substance in amounts or with methods which are harmful to themselves or others, and is a form of the substance-related disorder.
We know that if a person is consuming something like drug or alcohol he or she is taking something extra to his or her body which is harmful for the health of individual or for others also.
Drug addiction is a chronic disease characterized by drug seeking and use that is compulsive, or difficult to control, despite harmful consequences.
Brain changes that occur over time with drug use challenge an addicted person’s self-control and interfere with their ability to resist intense urges to take drugs. This is why drug addiction is also a relapsing disease.
Relapse is the return to drug use after an attempt to stop. Relapse indicates the need for more or different treatment.
Most drugs affect the brain's reward circuit by flooding it with the chemical messenger dopamine. This overstimulation of the reward circuit causes the intensely pleasurable "high" that leads people to take a drug again and again.
Drugs alter normal bodily functions by changing emotions and thoughts when absorbed into the body. Drug abuse is an intense desire to obtain drugs that results in physical harm and behavior problems over the long term. Substance abusers use substances in a way that damages themselves or society, while substance abuse counselors have training to help with addiction issues across different aspects. Substance abuse is a major problem impacting many in society as the most prevalent mental disorder and continuing health issue, with approximately 6-25% of the US population struggling with addiction or abuse of various legal and illegal substances.
This document discusses alcohol use disorders and their management. It begins with an overview of the epidemiology, terminology, classification, and complications of alcohol use disorders. Globally, around 107 million people have an alcohol use disorder, with prevalence in India being 1.12%. The reward pathway in the brain is stimulated by substances like alcohol. Screening tools can identify alcohol use and abuse. Management includes detoxification using benzodiazepines, treating comorbidities, using anti-craving drugs like Naltrexone or Acamprosate, and psychological therapies like motivational enhancement and group therapy. Follow up is also important for management.
Psychoactive Substance Use Disorders: Scope for Social Work - Tasmin KurienTasminKurien
A presentation on different psychoactive substances and the disorders caused by dependence and addiction on them. And what can social workers do about it.
- by Tasmin Kurien
Subject: Mental Health and Social Work
The document discusses various substances of abuse including definitions of substance abuse, intoxication, withdrawal, tolerance, polysubstance abuse, and dependence. It also discusses specific substances like alcohol, opioids, cocaine, amphetamines, cannabis, hallucinogens, inhalants, and nicotine. For each substance, signs and symptoms of intoxication and withdrawal are described as well as appropriate emergency treatment approaches.
The document discusses various substances that are commonly abused and their effects. It covers alcohol, hallucinogens like LSD and mushrooms, stimulants like cocaine and meth, marijuana, opiates like heroin, inhalants, MDMA (ecstasy), Rohypol (flunitrazepam), ketamine, and GHB. For each substance, it summarizes the intoxication effects, risks of long-term abuse like organ damage and addiction, and withdrawal symptoms. Nursing considerations are also discussed for assessing and treating patients with substance abuse and addiction issues.
This document discusses substance abuse and dependence criteria according to the DSM-IV as well as etiologic theories, family roles in substance abuse, withdrawal syndromes, and treatment options for various substances including alcohol, sedatives, stimulants, opioids, and cannabis.
This document summarizes a presentation given by a community psychiatric nurse on contributory factors to substance abuse. The presentation covered: definitions of key concepts like substance abuse, intoxication, and withdrawal; common substances abused; causes and contributing social/psychological factors; signs and symptoms; effects on health; and preventive measures. The goal was to raise awareness of substance abuse issues among parents at a school PTA meeting to help address this significant problem plaguing many communities.
Nearly half of the world's population is affected by mental illness which impacts self-esteem, relationships and ability to function. Good mental health allows one to realize their abilities and cope with stress, while poor mental health prevents a normal life. Mental health involves well-being and functioning well, while mental illness affects thinking, feelings and behavior. Risk factors for mental disorders include genetics, age, toxins, infections, and family/social problems. Both physical and mental health problems interact and influence each other. Prevention strategies target promotion, early intervention, treatment and social support/rehabilitation.
IT ABOUT THE SUBSTANCE RELATED DISORDER AND IMPULSE CONTROL NOTE THAT OUR GROUP PRESENTED. IT ABOUT DISORDER WHICH CAN BE FOUND AFTER USING DRUG. THE EFFECT OF DRUG AND THE BEHAVIOR OCCUR BY USING DRUG. WE ALSO DISCUSS ON ISLAMIC PERSPECTIVE ABOUT USING AND TAKING DRUG ILLEGALLY. HOW TO TREAT THE DRUG USER ALSO WE DISCUSS IT IN THIS SLIDE.
Substance use disorders are characterized by impaired control over substance use, social impairment, risky use, and pharmacological changes. The addiction cycle involves craving, compulsion, loss of control, and continued use despite consequences, driven by the brain's reward system and neurotransmitters like dopamine and serotonin. Risk factors include psychological, behavioral, social, demographic, family, and genetic factors. Around 9.3% of Americans currently use illicit drugs, most commonly marijuana and prescription pain relievers among teenagers. Alcohol and tobacco use is declining overall but binge drinking and opioid/heroin overdoses continue to rise significantly.
This document provides an overview of substance use and abuse, including definitions and classifications of alcohol abuse and dependence. It discusses the nature and risk factors of alcoholism, recognizing signs and symptoms, screening tools, medical complications, withdrawal, and treatment approaches. It also summarizes information on other commonly abused substances like opioids, sedatives, hallucinogens, marijuana, inhalants, steroids, and stimulants; outlining effects, dangers, dependence, withdrawal, and treatment considerations for each.
Substance Abuse
outlines
Definition
Factsheet
Risk factors
ICD classification
Sign and Symptom
The harmful effect of substance abuse on health and behaviour
Prevention and Rehabilitation for substance abusers
References
This document summarizes substance use disorders. It defines substances such as alcohol, opioids, cannabinoids, sedatives/hypnotics, cocaine, caffeine, hallucinogens, and tobacco. It describes how to identify substance use disorders through self-report data, analysis of bodily fluids, clinical signs and symptoms, and informant history. It then explains different classifications of substance use disorders including acute intoxication, harmful use, dependence syndrome, tolerance, withdrawal states, psychotic disorders, amnesic syndromes, and residual/late onset psychotic disorders. It provides examples of each classification.
- The document discusses dual diagnosis, which is when a person has both a substance misuse issue and a mental health disorder. It is common for the causes and symptoms to overlap.
- Dual diagnosis is a major issue, with around 3/4 of prisoners and 75-80% of drug/alcohol service users also experiencing mental health problems. Only 62% of drug users with mental health issues receive treatment.
- Having both a substance use disorder and mental illness leads to worse health outcomes and difficulties accessing care. The document advocates for services to better coordinate and meet people's full range of needs.
This document defines substance abuse and addiction. It discusses the classification of legal and illegal drugs, including alcohol, tobacco, cannabis, opioids, depressants, and stimulants. It outlines the signs and symptoms of substance abuse, as well as the health effects of commonly abused substances. Finally, it briefly discusses approaches to substance abuse prevention at the primary, secondary, and tertiary levels.
Kevin W. O'Neil, MD, FACP, CMD and Chief Medical Officer of Internal Medicine and Geriatrics reviews how to navigate the intricacies of substance abuse in older adults.
Mental health is about enhancing competencies of individuals and communities and enabling them to achieve their self-determined goals. Mental health should be a concern for all of us, rather than only for those who suffer from a mental disorder. Mental health problems affect society as a whole, and not just a small, isolated segment. They are therefore a major challenge to global development. This presentation focuses on the importance of mental health, the common substance abuse and their influence on mental health.
This document provides an overview of substance abuse for students. It defines substance abuse and distinguishes it from substance dependence. It discusses the prevalence of substance abuse among students, noting that marijuana and prescription drugs are the most commonly abused. The document outlines various signs and symptoms of substance abuse and how substances affect the brain. It also discusses factors influencing abuse, consequences of abuse, and medical treatments and resources available.
This document discusses substance use disorders and their classification in the DSM-V. It describes how substances directly activate the brain's reward system, causing feelings of pleasure. Individuals with lower self-control are more prone to developing substance use disorders, characterized by an inability to stop using a substance despite harm. The document outlines criteria for substance use disorders and withdrawal syndromes for different classes of substances, including alcohol, caffeine, cannabis, hallucinogens, inhalants, opioids, sedatives, stimulants, and tobacco. It also discusses biological, psychological and socio-cultural models of etiology.
This document discusses substance use disorders and different categories of abused substances. It defines substance intoxication, withdrawal, abuse, and dependence according to DSM-IV criteria. It then outlines 11 criteria for substance use disorder and notes changes in the DSM-5 definition. The document proceeds to describe characteristics of five categories of substances - depressants, stimulants, opioids, hallucinogens/PCP, and cannabis. Specific substances like alcohol, cocaine, amphetamines, nicotine, caffeine, heroin, LSD, and marijuana are discussed. Inhalants are also covered.
The document discusses various psychoactive substances including cocaine, amphetamines, and substances used to treat attention deficit disorder. It covers the history, pharmacology, effects, risks and treatment approaches for these substances.
Psychoactive Substance Use Disorders: Scope for Social Work - Tasmin KurienTasminKurien
A presentation on different psychoactive substances and the disorders caused by dependence and addiction on them. And what can social workers do about it.
- by Tasmin Kurien
Subject: Mental Health and Social Work
The document discusses various substances of abuse including definitions of substance abuse, intoxication, withdrawal, tolerance, polysubstance abuse, and dependence. It also discusses specific substances like alcohol, opioids, cocaine, amphetamines, cannabis, hallucinogens, inhalants, and nicotine. For each substance, signs and symptoms of intoxication and withdrawal are described as well as appropriate emergency treatment approaches.
The document discusses various substances that are commonly abused and their effects. It covers alcohol, hallucinogens like LSD and mushrooms, stimulants like cocaine and meth, marijuana, opiates like heroin, inhalants, MDMA (ecstasy), Rohypol (flunitrazepam), ketamine, and GHB. For each substance, it summarizes the intoxication effects, risks of long-term abuse like organ damage and addiction, and withdrawal symptoms. Nursing considerations are also discussed for assessing and treating patients with substance abuse and addiction issues.
This document discusses substance abuse and dependence criteria according to the DSM-IV as well as etiologic theories, family roles in substance abuse, withdrawal syndromes, and treatment options for various substances including alcohol, sedatives, stimulants, opioids, and cannabis.
This document summarizes a presentation given by a community psychiatric nurse on contributory factors to substance abuse. The presentation covered: definitions of key concepts like substance abuse, intoxication, and withdrawal; common substances abused; causes and contributing social/psychological factors; signs and symptoms; effects on health; and preventive measures. The goal was to raise awareness of substance abuse issues among parents at a school PTA meeting to help address this significant problem plaguing many communities.
Nearly half of the world's population is affected by mental illness which impacts self-esteem, relationships and ability to function. Good mental health allows one to realize their abilities and cope with stress, while poor mental health prevents a normal life. Mental health involves well-being and functioning well, while mental illness affects thinking, feelings and behavior. Risk factors for mental disorders include genetics, age, toxins, infections, and family/social problems. Both physical and mental health problems interact and influence each other. Prevention strategies target promotion, early intervention, treatment and social support/rehabilitation.
IT ABOUT THE SUBSTANCE RELATED DISORDER AND IMPULSE CONTROL NOTE THAT OUR GROUP PRESENTED. IT ABOUT DISORDER WHICH CAN BE FOUND AFTER USING DRUG. THE EFFECT OF DRUG AND THE BEHAVIOR OCCUR BY USING DRUG. WE ALSO DISCUSS ON ISLAMIC PERSPECTIVE ABOUT USING AND TAKING DRUG ILLEGALLY. HOW TO TREAT THE DRUG USER ALSO WE DISCUSS IT IN THIS SLIDE.
Substance use disorders are characterized by impaired control over substance use, social impairment, risky use, and pharmacological changes. The addiction cycle involves craving, compulsion, loss of control, and continued use despite consequences, driven by the brain's reward system and neurotransmitters like dopamine and serotonin. Risk factors include psychological, behavioral, social, demographic, family, and genetic factors. Around 9.3% of Americans currently use illicit drugs, most commonly marijuana and prescription pain relievers among teenagers. Alcohol and tobacco use is declining overall but binge drinking and opioid/heroin overdoses continue to rise significantly.
This document provides an overview of substance use and abuse, including definitions and classifications of alcohol abuse and dependence. It discusses the nature and risk factors of alcoholism, recognizing signs and symptoms, screening tools, medical complications, withdrawal, and treatment approaches. It also summarizes information on other commonly abused substances like opioids, sedatives, hallucinogens, marijuana, inhalants, steroids, and stimulants; outlining effects, dangers, dependence, withdrawal, and treatment considerations for each.
Substance Abuse
outlines
Definition
Factsheet
Risk factors
ICD classification
Sign and Symptom
The harmful effect of substance abuse on health and behaviour
Prevention and Rehabilitation for substance abusers
References
This document summarizes substance use disorders. It defines substances such as alcohol, opioids, cannabinoids, sedatives/hypnotics, cocaine, caffeine, hallucinogens, and tobacco. It describes how to identify substance use disorders through self-report data, analysis of bodily fluids, clinical signs and symptoms, and informant history. It then explains different classifications of substance use disorders including acute intoxication, harmful use, dependence syndrome, tolerance, withdrawal states, psychotic disorders, amnesic syndromes, and residual/late onset psychotic disorders. It provides examples of each classification.
- The document discusses dual diagnosis, which is when a person has both a substance misuse issue and a mental health disorder. It is common for the causes and symptoms to overlap.
- Dual diagnosis is a major issue, with around 3/4 of prisoners and 75-80% of drug/alcohol service users also experiencing mental health problems. Only 62% of drug users with mental health issues receive treatment.
- Having both a substance use disorder and mental illness leads to worse health outcomes and difficulties accessing care. The document advocates for services to better coordinate and meet people's full range of needs.
This document defines substance abuse and addiction. It discusses the classification of legal and illegal drugs, including alcohol, tobacco, cannabis, opioids, depressants, and stimulants. It outlines the signs and symptoms of substance abuse, as well as the health effects of commonly abused substances. Finally, it briefly discusses approaches to substance abuse prevention at the primary, secondary, and tertiary levels.
Kevin W. O'Neil, MD, FACP, CMD and Chief Medical Officer of Internal Medicine and Geriatrics reviews how to navigate the intricacies of substance abuse in older adults.
Mental health is about enhancing competencies of individuals and communities and enabling them to achieve their self-determined goals. Mental health should be a concern for all of us, rather than only for those who suffer from a mental disorder. Mental health problems affect society as a whole, and not just a small, isolated segment. They are therefore a major challenge to global development. This presentation focuses on the importance of mental health, the common substance abuse and their influence on mental health.
This document provides an overview of substance abuse for students. It defines substance abuse and distinguishes it from substance dependence. It discusses the prevalence of substance abuse among students, noting that marijuana and prescription drugs are the most commonly abused. The document outlines various signs and symptoms of substance abuse and how substances affect the brain. It also discusses factors influencing abuse, consequences of abuse, and medical treatments and resources available.
This document discusses substance use disorders and their classification in the DSM-V. It describes how substances directly activate the brain's reward system, causing feelings of pleasure. Individuals with lower self-control are more prone to developing substance use disorders, characterized by an inability to stop using a substance despite harm. The document outlines criteria for substance use disorders and withdrawal syndromes for different classes of substances, including alcohol, caffeine, cannabis, hallucinogens, inhalants, opioids, sedatives, stimulants, and tobacco. It also discusses biological, psychological and socio-cultural models of etiology.
This document discusses substance use disorders and different categories of abused substances. It defines substance intoxication, withdrawal, abuse, and dependence according to DSM-IV criteria. It then outlines 11 criteria for substance use disorder and notes changes in the DSM-5 definition. The document proceeds to describe characteristics of five categories of substances - depressants, stimulants, opioids, hallucinogens/PCP, and cannabis. Specific substances like alcohol, cocaine, amphetamines, nicotine, caffeine, heroin, LSD, and marijuana are discussed. Inhalants are also covered.
The document discusses various psychoactive substances including cocaine, amphetamines, and substances used to treat attention deficit disorder. It covers the history, pharmacology, effects, risks and treatment approaches for these substances.
This document discusses stimulant drugs such as caffeine, nicotine, cocaine, and amphetamines. It explains that stimulants increase alertness, attention, and energy by enhancing neurotransmitters like norepinephrine and dopamine in the brain. Short-term effects include feelings of euphoria, but long-term abuse can lead to addiction, paranoia, irregular heartbeat, and seizures. Caffeine is the world's most commonly used psychoactive drug, found in coffee, tea, chocolate, and some medicines. While caffeine provides alertness, too much can cause cardiovascular problems, ulcers, and anxiety over time. Withdrawal from caffeine addiction brings on headaches, tiredness, and irritability.
This document summarizes different classes of antidepressants and mood stabilizers. It discusses how antidepressants like SSRIs, SNRIs, and TCAs work to block neurotransmitter reuptake in the brain. It provides examples of common medications in each class and their indications and side effects. Mood stabilizers discussed include lithium, anti-convulsants like carbamazepine, valproate, and lamotrigine which are used to treat bipolar disorder.
This document discusses various commonly abused substances including amphetamines, cocaine, MDMA, synthetic cathinones, LSD, marijuana, synthetic cannabinoids, ethanol, and prescription drugs. It describes their mechanisms of action, effects, routes of administration, toxicity, and medical management for overdoses. Drug abuse is a serious public health issue and substances have become more potent and addictive over time.
Antidepressants work by blocking the reuptake of serotonin and norepinephrine in the brain. They are used to treat conditions like depression, chronic pain, and family history of depression. Common types include SSRIs, SNRIs, and tricyclics. Side effects may include dry mouth, constipation, blurred vision, and weight gain. Mood stabilizers like lithium and anticonvulsants are used to treat bipolar disorder and prevent manic episodes. Lithium requires blood monitoring due to risk of toxicity. Side effects can include tremors, nausea, weight gain, and decreased thyroid function.
1. Parkinsonism is a progressive neurodegenerative disorder caused by loss of dopamine-producing neurons in the substantia nigra, leading to motor symptoms like bradykinesia, rigidity, resting tremor, and impaired balance.
2. Treatment aims to restore dopamine levels through levodopa or dopamine agonists to improve motor symptoms, and anticholinergics to reduce acetylcholine activity in the striatum.
3. Levodopa is most effective but side effects emerge with long term use, so combinations with carbidopa are used to sustain dopamine levels and minimize side effects.
This document discusses central nervous system (CNS) stimulant drugs, including cocaine, amphetamines, and methamphetamines. It defines stimulants and lists their medical uses and desired and toxic effects. It covers the pharmacokinetics and pharmacodynamics of cocaine and amphetamines, including their mechanisms of action, metabolism, and clinical effects during acute and chronic use. The document also discusses withdrawal symptoms and treatments for dependence and intoxication from CNS stimulants.
The document discusses antidepressants and antipsychotics used to treat mental disorders like depression, anxiety, psychoses, and affective disorders. It describes the pathophysiology involving biochemical imbalances and provides examples of drug categories and specific medications used, including their mechanisms of action, indications, side effects, cautions, and monitoring considerations for safe and effective use. Nursing care involves patient education, monitoring for therapeutic effects and side effects, and ensuring safe administration of these medications.
This document provides information on substance-related disorders including substance abuse, dependence, withdrawal, and intoxication. It defines substance abuse and dependence based on DSM-IV criteria. It describes the epidemiology, categories, and effects of commonly abused substances like stimulants, depressants, opiates, hallucinogens, inhalants, and caffeine. For each substance or class, it summarizes intoxication, withdrawal, treatment approaches, and diagnostic evaluation.
Stimulants are substances that increase behavioral activity when administered. They are classified as psychomotor stimulants or hallucinogens. Psychomotor stimulants like cocaine, amphetamines, and nicotine cause excitement, euphoria and increased motor activity by increasing the neurotransmitters dopamine and norepinephrine. Hallucinogens affect thought patterns and mood but have little effect on the brain stem and spinal cord. Common stimulants include caffeine, nicotine, cocaine, amphetamines, and methylphenidate.
This document summarizes key information about several neurotransmitters and psychopharmacological drugs. It describes the functions and effects of neurotransmitters like dopamine, norepinephrine, serotonin, GABA, and acetylcholine. It then discusses several classes of psychotropic medications like antipsychotics, antidepressants, mood stabilizers, benzodiazepines, and stimulants. For each drug class, it provides examples of specific medications, their indications, mechanisms of action, side effects, and important considerations for monitoring safety and efficacy.
Neurodegenerative Disorders Pharmacotherapy Dr Jayesh Vaghelajpv2212
This document discusses pharmacotherapy for neurodegenerative disorders. It provides an overview of mechanisms of neuronal cell death like protein misfolding and aggregation. It then discusses selective vulnerability in different disorders and neuroprotective strategies. For Parkinson's disease specifically, it covers the introduction, etiology, pathophysiology, clinical manifestations, and pharmacotherapy including levodopa, dopamine agonists, COMT inhibitors, and their advantages and adverse effects.
Parkinson's disease is a progressive nervous system disorder that affects movement. It results from loss of dopamine neurons in the substantia nigra. Symptoms include tremor, rigidity, bradykinesia, and impaired balance. While the cause is largely unknown, risk increases with age. Treatment focuses on managing symptoms, primarily through dopamine replacement therapy using levodopa and dopamine agonists. Adverse effects can include dyskinesia and psychiatric issues. Managing Parkinson's becomes more challenging over time as symptoms fluctuate and complications arise.
The document discusses drugs and their effects on the human body. It defines what a drug is and different types of drugs including depressants, stimulants, and hallucinogens. It then describes common drugs like cocaine, marijuana, ketamine and sleeping pills. It outlines both short term effects like changes in mood and behavior as well as long term health consequences of drug abuse like brain damage, infections and death. The document also discusses signs of drug abuse and compares physical effects on the body and brain of drug users versus non-users.
This document provides information about various drugs and their effects. It defines drugs as chemicals that affect the mind and body, and can lead to physical or psychological dependence. It then lists common reasons why teens try drugs, such as peer pressure or lack of other activities. The document describes different types of drugs including stimulants, depressants, hallucinogens, and discusses specific drugs like alcohol, nicotine, marijuana, heroin, cocaine, prescription drugs. It outlines the short-term and long-term effects of each drug type on the body and brain. The document emphasizes that drug use can seriously harm health and lead to addiction, overdose, death, or legal and social consequences.
This document discusses CNS stimulants and cognition enhancers. It describes various psychomotor stimulants like amphetamines, cocaine, nicotine, and hallucinogens. It discusses their mechanisms of action, effects on the CNS and sympathetic nervous system, therapeutic uses, and adverse effects. It also covers cognition enhancers used for conditions like dementia and Alzheimer's disease. These include cholinergic activators like donepezil and memantine, as well as supplements like Ginkgo biloba. The document provides an overview of how cognition enhancers work to improve brain function and memory.
This document discusses several classes of psychoactive drugs, including psychomotor stimulants, hallucinogens, and nicotine. Psychomotor stimulants like amphetamines increase alertness and motor activity, while hallucinogens alter mood and thought patterns. Nicotine is highly addictive and can increase heart rate and blood pressure. The document also provides information on specific drugs, their mechanisms of action, therapeutic uses, and adverse effects.
This document provides information on various medications that affect the nervous system. It discusses categories of medications like cholinesterase inhibitors, neuromuscular blocking agents, antiepileptics, antidepressants, antipsychotics, anxiolytics, sedatives and more. For each category, it lists example medications and provides details on their expected actions, therapeutic uses, adverse effects, contraindications, precautions, interactions and important points for patient education. Receptors like muscarinic, nicotinic, alpha, beta and dopamine receptors are also explained in relation to medication effects. Conditions like Parkinson's disease, seizures, schizophrenia, depression and bipolar disorder are overviewed in terms of their typical treatment approaches.
This document discusses merging or augmenting course sites on Blackboard. It provides examples of when merging or augmenting may be useful, such as for multiple sections, co-taught sections, or co-listed sections. It describes the difference between merging sites, which hides the original sites, and augmenting sites, which makes items shared in a combined site but keeps original sites visible. It also provides instructions for how to request that course sites be merged or augmented by emailing Blackboard support with the course details and specifying whether a merge or augment is needed.
This document discusses how to use a wiki in a Blackboard course. A wiki allows for collaborative writing and editing of content. Wikis can be used for group work, authentic audiences, and writing to learn. To set up a wiki in Blackboard, an instructor first organizes the content and creates a wiki document. They then generate wiki pages and links between pages. The instructor also adds a link from their course to the wiki. Finally, the wiki can be assessed through participation and grading features.
Blackboard Learn Course Customization: Teaching Styles and PropertiesUniversity of Miami
This document discusses how to customize courses by selecting teaching styles and properties. It explains that customization allows instructors to differentiate, organize, plan, and assist students. Teaching styles and properties can be found and selected on specific pages in the course customization tool. The document also provides a demonstration of customizing courses using styles and properties.
This document provides an overview of the Blackboard Calendar tool for instructors. It explains that the Calendar can be used to remind students of upcoming due dates, manually add items like lectures, drag and drop items to move them, and bulk move due dates. It also advertises an upcoming demonstration of the Calendar tool by Bill Vilberg and provides his contact information for questions.
The document discusses Blackboard Mobile, which allows students at UMiami to access course sites, announcements, documents and participate in discussions on their mobile devices. It highlights features like taking tests, using the Respondus Lockdown browser, and integrating with Dropbox and Google Docs. The slides are available online and it encourages keeping the app updated as mobile learning is still a work in progress at the university.
This document provides instructions for creating online sign-up sheets for student presentations using Blackboard Groups. It outlines creating a group set with sign-up sheets only and no other tools enabled. It then explains how to add a tool link to the main menu to make the sign-up sheets available for students to view and sign up for presentation time slots on specific dates.
SafeAssign is a plagiarism detection tool available through Blackboard that analyzes student assignments for originality. When an instructor creates a SafeAssignment, students submit their work which is analyzed on an external server. A report is then made available to both the student and instructor showing how much of the submitted content matches content in SafeAssign's databases, which include the internet, academic databases, and submissions from other institutions. SafeAssign is used across various disciplines at the university, with over 3,000 submissions and 187 assignments in the spring 2014 semester alone.
Flipping the Classroom: Flipping a Lesson Using Bloom's Taxonomy University of Miami
This document discusses flipping the classroom using Bloom's Taxonomy. It defines flipping as receiving instruction at home (through videos or other media) and doing homework and processing the material in class. The document recommends determining a "cognitive cutoff" point based on Bloom's Taxonomy to decide what content is covered at home versus in class. A six step process is outlined for flipping a lesson that involves writing objectives, organizing by Bloom's level, determining the cognitive cutoff, planning pre-class and in-class activities, and evaluating results to improve the lesson. Potential uses, concerns, and implications of flipping are also addressed.
O documento discute a importância da higiene das mãos para prevenir infecções hospitalares. Estimativas indicam que mais de 1,4 milhão de pessoas no mundo sofrem de infecções adquiridas em hospitais, causando custos significativos. A lavagem correta das mãos é a estratégia fundamental para reduzir a disseminação de microrganismos entre pacientes e profissionais de saúde.
O documento discute prioridades de pesquisa em enfermagem na área de segurança dos pacientes. Aborda a importância da produção de conhecimento científico para melhorar a qualidade e segurança dos cuidados de saúde. Também destaca desafios como o desenvolvimento de uma cultura de segurança e estudos sobre a percepção de profissionais e pacientes em relação aos riscos na assistência à saúde.
O documento discute o papel crucial das enfermeiras na promoção da segurança do paciente. Ele destaca que as enfermeiras são agentes-chave para liderar iniciativas de segurança do paciente e implementar ações comprovadas para reduzir eventos adversos. No entanto, muitos desafios institucionais e culturais dificultam esses esforços, como a falta de mudança cultural e sistemas inadequados. É necessária uma liderança forte e uma cultura de aprendizado para criar um ambiente seguro para os pacientes.
La violencia doméstica ocurre en todas las poblaciones y más de 1 de cada 3 mujeres y hombres en los EE.UU. han sido víctimas de violencia por parte de su pareja íntima. Las mujeres representan la mayoría de las víctimas. La violencia doméstica tiene graves consecuencias para la salud física y mental de las víctimas y sus familias, así como consecuencias sociales y económicas.
Este documento define la violencia doméstica y discute las definiciones legales y sociales. Explica que la violencia doméstica incluye la violencia física, sexual, psicológica y económica entre miembros de una pareja íntima o familia. También describe los diferentes tipos de violencia doméstica y la importancia de tener definiciones comunes para abordar y medir adecuadamente este problema.
Este documento describe las funciones y responsabilidades de los enfermeros al tratar casos de violencia doméstica. Los enfermeros deben prevenir, detectar e intervenir en casos de violencia doméstica mediante la educación, la detección rutinaria, la evaluación del riesgo, el desarrollo de planes de seguridad y la derivación a recursos comunitarios. También deben cumplir con los requisitos de denuncia obligatoria cuando se sospecha abuso de niños o adultos vulnerables.
Este documento presenta varias teorías y marcos conceptuales sobre la violencia doméstica, incluyendo perspectivas psicológicas, biológicas, de sistemas familiares y sociológicas. La teoría más ampliamente utilizada es el modelo ecológico de la OMS, que considera factores a nivel individual, de la relación, comunitario y social. También se describe la rueda del poder y control, que ilustra cómo se establece el control sobre las víctimas a través de diferentes tácticas, y el c
O documento discute os resultados do Estudo IBEAS sobre eventos adversos na América Latina, mostrando que a maioria estava relacionada a infecções. Também apresenta soluções para aumentar a segurança do paciente, como a lista de verificação cirúrgica, que reduziu complicações e mortalidade quando implementada. A instância prévia, momento para checar procedimentos antes de iniciar, também é importante para prevenir erros.
El documento describe las prácticas para prevenir y controlar la infección por VIH y otros patógenos transmitidos por la sangre. Explica que las precauciones estándar como la higiene de manos, el uso de equipo de protección personal y las soluciones de lejía son esenciales para todos los pacientes. También cubre la profilaxis post-exposición, que incluye el tratamiento antirretroviral después de una exposición ocupacional a la sangre infectada para reducir el riesgo de transmisión del VIH y la hepatitis.
Este documento describe el ciclo de vida del virus VIH y las diferentes clases de medicamentos antirretrovirales utilizados para tratar la infección por VIH. Explica las 6 etapas del ciclo de vida del VIH, desde que se une a las células CD4 hasta la muerte celular. También detalla las 6 clases principales de medicamentos antirretrovirales, incluidos los inhibidores de la transcriptasa inversa, la proteasa y la integrasa. Por último, resume las recomendaciones actuales sobre el tratamiento de la infección por VIH
Este documento describe el VIH y las pruebas para detectarlo. Explica que existen dos tipos de VIH (VIH-1 y VIH-2) y que la prueba ELISA se usa primero para detectar anticuerpos, seguida de una prueba de confirmación Western Blot si es positiva. También identifica a las poblaciones con mayor riesgo de contraer VIH y recomienda que los profesionales médicos ofrezcan exámenes de detección como parte de la atención rutinaria. Además, enfatiza la importancia
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
share - Lions, tigers, AI and health misinformation, oh my!.pptxTina Purnat
• Pitfalls and pivots needed to use AI effectively in public health
• Evidence-based strategies to address health misinformation effectively
• Building trust with communities online and offline
• Equipping health professionals to address questions, concerns and health misinformation
• Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxwalterHu5
In some case, your chronic prostatitis may be related to over-masturbation. Generally, natural medicine Diuretic and Anti-inflammatory Pill can help mee get a cure.
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Substance abuse[2]
1.
2. Substance Abuse
Substance abuse
– Use of drug interferes with ability to function
Fails to meet work or family obligations
– No physiological dependence
Substance dependence (addiction)
– Involves either tolerance or withdrawal
– Tolerance
Greater and greater amounts of substance are needed to produce
the desired effect
– Withdrawal
Physiological and psychological consequences when individual
discontinues or reduces substance use
– Restlessness, anxiety, cramps, death
3. Alcohol-Related Disorders
Discontinuation of alcohol in heavy user:
– Anxiety
– Depression
– Weakness
– Restlessness
– Difficulty sleeping
– Muscle tremors
• Face, fingers, eyelids, other small musculature
– Elevated BP, pulse, temperature
4. Management of Alcohol
Withdrawal
General Measures
Seizure precautions with h/o Sz
Hydration
Thiamine 100mg IM/IV prior to glucose
Correct electrolytes—Mg, Ca, K, PO4
Treat concurrent illnesses
5. Management of AWS
Benzodiazepines (BDZ)
Treatment of choice
Reduce symptoms and decrease risk of Seizurezs
Phenobarbital
Narrow therapeutic index
Carbamazepine
Effective alternative, less sedation
Mayo-Smith JAMA 1997;278:144-51
6. Choice of Benzodiazepine
All seem effective for AWS
Limited comparative data
All metabolized by liver
Differences
Onset of action, half life, routes
1 or 2 step metabolism; active metabolites
Long vs shorter acting
7. Long-acting Benzodiazepines
Chlordiazepoxide (Librium®)
Oral dosing only
Intermediate onset
Long-acting parent compound and metabolites
Smoother withdrawal, less sz, better cognitive fxn
Potential accumulation in elderly and patients with liver
disease
[Diazepam]
8. Shorter-acting BDZs
Lorazepam (Ativan®)
Versatile dosing—PO, IV, IM, SL
Fast to intermediate onset
Intermediate half-life, no metabolites
Less likely to accumulate in elderly or with liver
disease
Breakthrough sx, met. acidosis, delirium
[Oxazepam]
10. Benzodiazepines
Route of administration
Oral preferable
Ease of administration
More consistent blood levels
Sublingual if NPO
(e.g., surgical patients)
Intravenous
Severe w/d requiring rapid titration or NPO
11. Amphetamine Related
Disorder
DSM IV
Amphetamine induced
Anxiety disorder
Mood disorder
Psychotic disorder with delusions
Psychotic disorder with hallucinations
Sexual dysfunction
12. Amphetamine Related
Disorder
Treatment
None established
Treat specific symptoms
Comorbid conditions such as depression may
respond to antidepressants
Bupropion (Wellbutrin)
Used after patients withdraw from amphetamines
13. Caffeine-Related Disorder
Caffeine is an methylxantine
More potent than other known methylxantines
Theophyline (Primatene)
Half-life- 3-10 hrs
Peak 30-60 minutes
Crosses BBB
Adenosine-receptor antagonist
14. Amount of Caffeine
Consumption
Beverages / Food:
Cup of coffee: 65-120 mg caffeine
Espresso 1oz shot: 40 mg
Cup of tea: 40-60 mg
Can of soda: 30-60 mg
Red Bull (8.3oz): 80 mg
Hershey’s milk chocolate almond bar (6oz): 25mg
Over the counter medicines:
No-Doze: 100 – 200 mg
Midol: 20-100 mg
Excedrin: 30-65 mg
Benowitz, 1990
Total consumption of caffeine per person per day is estimated at
210 to 238 mg (Barone and Roberts, 1996)
15. Mechanism of Action
Three main hypotheses:
1. Mobilization of intracellular calcium
Biphasic effect on intracellular calcium levels
*Toxic amounts of caffeine
2. Inhibition of phosphodiesterase
Inhibition of enzyme that breaks down cyclic adenosine monophosphate
(cAMP)
*Toxic amounts of caffeine
3. Antagonism of inhibitory presynaptic adenosine receptors
Caffeine blocks adenosine receptors
Resulting in the inhibition of the breakdown of cAMP
Blocking the inhibitory effects of adenosine
Nehlig et al., 1992
16. Pharmacodynamics
Caffeine
Central Nervous System Enhances neurotransmitter release
Stimulates locomotor activity
Decreases cerebral blood flow
Cardiovascular Release of epinephrine (adrenaline) which
Increases heart rate
Increases blood pressure
Increases blood flow to the muscles
Decreases blood flow to skin and inner
organs
Renal Diuresis; stimulates renal release
Vasculature Peripheral: Dilation
Central: Constriction
Gastrointestinal Increases gastric secretions
Respiratory Bronchodilation
Increases respiratory rate
Garrett and Griffiths 1997
17. Pharmacokinetics
Absorption
Gastrointestinal tract and stomach
Rapid rate, peak blood level in 30-60 min.
Crosses lipid-membrane (not water soluble)
Distribution
Diffuses throughout the organism and crosses BBB
Including placenta and placental BBB
Nehlig et al., 1999; Fredholm et al., 1999
18. Pharmacokinetics
Metabolism
Metabolized through liver biotransformation initially by demethylation into
dimethylxanthines.
*Dimethylxanthines are pharmacologically active and may add to the
effects of caffeine consumption in humans.
This process is unique to humans, no other animal species metabolizes
caffeine in a similar way
Half life of caffeine
Three to eight hours; varies with age and other external factors
Newborns cannot metabolize caffeine, mainly eliminated by excretion
Half life 80 +/_ 23 hours
Smokers, half life is reduced up to 50%
Pregnant women and those taking oral contraceptive, half life up to 15
hours longer
Nehlig et al., 1999; Fredholm et al., 1999
19. Treatment of Caffeine-Related
Disorders
Reducing or eliminating caffeine
consumption
ASA
Headaches, muscle aches from withdrawal
Benzodiazepines-rarely required
20. Cannabis-Related Disorders
Major active ingredient Physiological
– THC (delta-9- – Bloodshot & itchy eyes
tetrahydrocannabinol) – Dry mouth and throat
• Psychological – Increased appetite
– Feelings of relaxation and – Reduced pressure within the
sociability eye
– Rapid shifts of emotion – Reduced BP
– Interferes with attention, – Abnormal heart rate
memory, and thinking • May exacerbate preexisting
– Heavy doses can induce cardiovascular problems
hallucinations and panic – Damage to lung structure and
– Impairment of skills needed function
for driving – Tolerance may develop
• Impairment present for
several hours after ‘high’ has
worn off
21. Cannabis Withdrawal
No specific treatment
Abstinence and support
Anxiolytics
Short-term withdrawal symptoms relief
If depressive disorder is present, treat with
antidepressants
22. Cocaine-Related Disorder
Alkaloid obtained from coca Overdose
leaves – Chills, nausea, insomnia,
– Reduces pain paranoia, hallucinations, and
– Produces euphoria other psychotic symptoms
– Heightens sexual desire – Can cause heart attack and
– Increases self-confidence and death because drug causes
indefatigability blood vessels to narrow
Blocks reuptake of dopamine in • Not all users develop tolerance
mesolimbic areas of brain – Some become more sensitive
• May increase risk of OD
• Usage increased in 70s and 80s
– Dropped late 80s; rose mid 90s
In 2003, 2.3 million users over
the age of 12 (SAMHSA, 2004)
23. Cocaine-Related Disorder
Crack
– Form of cocaine that become popular in the
80s
– Rock crystal that is heated, melted, & smoked
– Increased popularity because it is cheaper than
cocaine
24. Cocaine-Related Disorder
Treatment
No pharmacological treatments produce decreases in
cocaine use comparable to the decreases in opioid use
when heroin users are treated with methadone,
levomethadyl and buprenorphine.
Methylphenidate (Ritalin),Lithium (Eskalith)
Cocaine users presumed to have preexisting ADHD and
mood disorders
Those drugs are useless in patients without the
disorders
25. Cocaine-Related Disorder
Treatment, cont.
Many different treatments have been use with
little or no effects
TCAs
MAOIs
SSRIs
Antipsychotics
Etc.
26. Hallucinogen-Related Disorders
Natural and synthetic substances
Psychedelics or psychomimetics
Induce hallucinations or disconnection with reality
Schedule 1 drugs
28. Hallucinogen-Related Disorders
LSD
Synthesized in 1938
Classic synthetic hallucinogen
MDMA- erroneously classified as a hallucinogen,
vstructirally related to amphetamines
29. Hallucinogen-Related Disorders
Treatment
Symptom specific
Psychological support
Hallucinogen intoxication can be treated with
diazepam 20 mg
Stops LSD effect and associated panic to a stop
within 20 minutes
33. Inhalants-Related Disorders
Intoxication requires no medical attention
Effects of intoxication may require attention
Coma, bronchospasm, laryngospasm, cardiac
arrhythmias, or burns
Sedation is contraindicated
Confusion, panic or psychosis
Severe agitation
Haloperidol 5mg IM/70 kg bw